NucleoTech
Effective Drug Delivery to the Brain
Active
Pre-Funding
Startup
Rehovot
Founded 2023-01
To date, many brain conditions are poorly medicated due to limitations in drug-delivery prevent treating patients efficiently. The prominent reason is the Blood Brain Barrier (BBB), which prevents most therapeutic molecules from reaching the brain – and severely limits the arsenal of brain therapeutics. NucleoTech is developing carriers that deliver a varie…
SectorHealth Tech & Life Sciences
StagePre-Funding
Employees7
Founded2023-01
HQRehovot
Confidence88
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals